ClariVest Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,262
Closed -$351K 963
2023
Q3
$351K Sell
22,262
-9,030
-29% -$142K 0.02% 364
2023
Q2
$609K Buy
31,292
+6,988
+29% +$136K 0.03% 323
2023
Q1
$690K Buy
24,304
+31
+0.1% +$880 0.03% 338
2022
Q4
$709K Sell
24,273
-216
-0.9% -$6.31K 0.03% 332
2022
Q3
$646K Sell
24,489
-27
-0.1% -$712 0.03% 324
2022
Q2
$1.09M Sell
24,516
-6,630
-21% -$295K 0.05% 267
2022
Q1
$1.54M Buy
31,146
+6,485
+26% +$321K 0.06% 238
2021
Q4
$1.26M Sell
24,661
-918
-4% -$46.7K 0.04% 290
2021
Q3
$1.43M Buy
25,579
+14,766
+137% +$824K 0.05% 275
2021
Q2
$463K Buy
10,813
+25
+0.2% +$1.07K 0.02% 437
2021
Q1
$450K Sell
10,788
-18,340
-63% -$765K 0.02% 428
2020
Q4
$1.36M Sell
29,128
-15,869
-35% -$739K 0.05% 239
2020
Q3
$1.91M Sell
44,997
-1,464
-3% -$62.2K 0.06% 232
2020
Q2
$2.23M Buy
46,461
+780
+2% +$37.4K 0.06% 218
2020
Q1
$2.1M Buy
45,681
+905
+2% +$41.6K 0.06% 192
2019
Q4
$2.69M Sell
44,776
-19,737
-31% -$1.19M 0.06% 213
2019
Q3
$3.65M Sell
64,513
-1,000
-2% -$56.6K 0.08% 192
2019
Q2
$3.65M Buy
65,513
+14,427
+28% +$803K 0.08% 190
2019
Q1
$2.58M Sell
51,086
-2,720
-5% -$137K 0.05% 286
2018
Q4
$2.17M Buy
53,806
+13,971
+35% +$563K 0.05% 295
2018
Q3
$2.76M Sell
39,835
-615
-2% -$42.6K 0.05% 266
2018
Q2
$3.06M Buy
+40,450
New +$3.06M 0.05% 280
2016
Q2
Sell
-16,619
Closed -$673K 700
2016
Q1
$673K Buy
16,619
+616
+4% +$24.9K 0.02% 329
2015
Q4
$1.42M Sell
16,003
-421
-3% -$37.3K 0.04% 232
2015
Q3
$1.22M Sell
16,424
-4,093
-20% -$303K 0.04% 250
2015
Q2
$1.66M Buy
20,517
+11,917
+139% +$963K 0.05% 226
2015
Q1
$360K Sell
8,600
-4,500
-34% -$188K 0.01% 356
2014
Q4
$204K Buy
13,100
+300
+2% +$4.67K 0.01% 343
2014
Q3
$162K Buy
+12,800
New +$162K 0.01% 391